XBiotech Inc.
XBIT
$8.61
-$0.72-7.72%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -93.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -93.33% |
| Cost of Revenue | -- | -- | -- | -- | -98.47% |
| Gross Profit | -- | -- | -- | -- | -91.78% |
| SG&A Expenses | -30.65% | 15.83% | -34.11% | -30.37% | -39.50% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.48% | 5.59% | -2.69% | -14.38% | -27.64% |
| Operating Income | -5.21% | -33.35% | -9.62% | 8.92% | -13.46% |
| Income Before Tax | -80.34% | 31.21% | 39.16% | 40.30% | 65.77% |
| Income Tax Expenses | -117.13% | -87.17% | 102.72% | 96.51% | 148.13% |
| Earnings from Continuing Operations | -44.71% | 41.82% | 24.92% | 29.27% | 50.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -44.71% | 41.82% | 24.92% | 29.27% | 50.47% |
| EBIT | -5.21% | -33.35% | -9.62% | 8.92% | -13.46% |
| EBITDA | -5.62% | -43.02% | -12.81% | 6.07% | -18.90% |
| EPS Basic | -44.77% | 41.82% | 24.92% | 29.23% | 50.54% |
| Normalized Basic EPS | -80.33% | 31.20% | 39.17% | 40.30% | 65.80% |
| EPS Diluted | -47.81% | 41.82% | 24.92% | 29.23% | 50.61% |
| Normalized Diluted EPS | -80.33% | 31.20% | 39.17% | 40.30% | 65.80% |
| Average Basic Shares Outstanding | 0.01% | -0.01% | 0.00% | 0.00% | 0.10% |
| Average Diluted Shares Outstanding | 0.01% | -0.01% | 0.00% | 0.00% | 0.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
